Name
Osaühing MEREKIVI PEREARSTID
Registry code
10716455
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
20.12.2000 (23)
Financial year
01.01-31.12
Capital
2 568.00 €
Activity
86211 - Provision of general medical treatment
712 539 €
136 060 €
19%
1 879 €
(estimate is approximate)
356 736 €
10
Submitted
No tax arrears
38%
35%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Helena Hansen 05.09.1969 (55) | 50% - 1 284.00 EUR | Board member | Direct ownership | Founder |
| Iris Koort 30.09.1963 (61) | 50% - 1 284.00 EUR | Board member | Direct ownership | Founder |
| Kaia Kiiroja 20.01.1966 (58) | - | - | - | Founder |
| 2019 22.05.2020 | 2020 28.06.2021 | 2021 22.06.2022 | 2022 02.07.2023 | 2023 19.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 621 231 € | 427 008 € | 494 978 € | 584 025 € | 712 539 € |
| Net profit (loss) for the period | 97 509 € | 84 870 € | 102 582 € | 128 603 € | 136 060 € |
| Profit Margin | 16% | 20% | 21% | 22% | 19% |
| Current Assets | 260 707 € | 300 181 € | 341 702 € | 409 450 € | 387 125 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 260 707 € | 300 181 € | 341 702 € | 409 450 € | 387 125 € |
| Current Liabilities | 19 527 € | 17 142 € | 20 597 € | 24 258 € | 30 389 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 241 180 € | 283 039 € | 321 105 € | 385 192 € | 356 736 € |
| Employees | 9 | 7 | 7 | 7 | 10 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 28 767.26 € | 30 781.66 € | 9 |
| 2023 Q4 | - | 52 413.83 € | 29 385.46 € | 9 |
| 2023 Q3 | - | 46 241.46 € | 37 467.17 € | 10 |
| 2023 Q2 | - | 25 479.21 € | 27 257.33 € | 10 |
| 2023 Q1 | - | 25 774.59 € | 27 581.94 € | 10 |
| 2022 Q4 | - | 25 813.06 € | 27 639.45 € | 10 |
| 2022 Q3 | - | 40 631.26 € | 32 058.86 € | 10 |
| 2022 Q2 | - | 21 374.16 € | 22 990.63 € | 10 |
| 2022 Q1 | - | 31 298.66 € | 33 691.95 € | 10 |
| 2021 Q4 | - | 21 428.53 € | 23 063.33 € | 10 |
| 2021 Q3 | - | 22 424.53 € | 24 222.16 € | 9 |
| 2021 Q2 | - | 34 003.15 € | 25 026.35 € | 9 |
| 2021 Q1 | - | 21 276.81 € | 22 991.16 € | 9 |
| 2020 Q4 | - | 16 936.05 € | 18 287.15 € | 9 |
| 2020 Q3 | - | 27 214.44 € | 21 570.57 € | 8 |
| 2020 Q2 | - | 17 511.56 € | 18 910.94 € | 8 |
| 2020 Q1 | - | 22 209.68 € | 23 992.9 € | 8 |
